1.
Parasite. 2019;26:13. doi: 10.1051/parasite/2019013. Epub 2019 Mar 6.

Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy.

Author information

1
Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA - Department of Medicine and Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA - Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
2
Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA.
3
Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, CA, USA - Department of Medicine and Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Abstract

We assessed clinical and serologic findings in 25 infants with congenital toxoplasmosis born to mothers treated during pregnancy in the United States. Results indicate a lower prevalence of eye findings and hydrocephalus in the group of infants born to treated mothers (62.5% and 38.5%, respectively) compared to results on the same pathologies reported in our previous cohort of infants born to untreated mothers (92.2% and 67.7%, respectively). The sensitivity of the IgM ISAGA and IgA ELISA in the present study were lower (44% and 60%, respectively) compared to sensitivity of these methods in our previously studied group of infants born to untreated mothers (86.6% and 76.5%, respectively). These findings provide further evidence that anti-parasitic treatment if administered during pregnancy can contribute to better clinical outcomes, even in countries where systematic screening and treatment have not been routinely implemented.

PMID:
30838974
DOI:
10.1051/parasite/2019013
Free full text
Icon for EDP Sciences

Supplemental Content

Loading ...
Support Center